4-methyl-2-(5-pyridin-4-yl-1,3,4-oxadiazol-2-yl)aniline, 95.0%, 5g

2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol, 95.0%, 250mg

(7-Methyl-1H-indazol-5-yl)boronic acid, 95.0%, 1g

Cell culture dishes Suspension, 58 cm², 13 ml, 100 mm 300 pieces

(2E)-3-(4-bromophenyl)-3-chloroacrylaldehyde, 95.0%, 1g

Helicin>98.0%(HPLC)1g

3-CYANO-N-(1,3-DIPHENYL-1H-PYRAZOL-5-YL)BENZAMIDE, 95%, 100mg

N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide, 98%, 5mg

N-Acetyl-D-mannosamine, min. 98%, 5 g, plastic packaging.

1-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]ethanamine, 95.0%, 1g

1-(4-Nitrophenyl)-5-(trifluoromethyl)pyrazole-4-carboxylic acid, 98.0%, 5g

3,4-DIHYDRO-2H-PYRIDO[4,3-B][1,4]OXAZINE, 95.0%, 5g

2-Nitrothiophene (contains 3-Nitrothiophene)>80.0%(GC)5g